Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome

被引:38
作者
Verges, B. [1 ]
Avignon, A. [2 ]
Bonnet, F. [3 ]
Catargi, B. [4 ]
Cattan, S. [5 ]
Cosson, E. [6 ]
Ducrocq, G. [7 ]
Elbaz, M. [8 ]
Fredenrich, A. [9 ]
Gourdy, P. [10 ]
Henry, P. [11 ]
Lairez, O. [8 ]
Leguerrier, A. M. [3 ]
Monpere, C. [12 ]
Moulin, P. [13 ]
Verges-Patois, B. [14 ]
Roussel, R. [15 ]
Steg, G. [7 ]
Valensi, P. [6 ]
机构
[1] CHU, Hop Bocage, Serv Endocrinol Diabetol & Malad Metab, F-21000 Dijon, France
[2] CHU Montpellier, Serv Malad Metab, F-34000 Montpellier, France
[3] CHU Rennes, Serv Endocrinol Diabetol & Nutr, F-35000 Rennes, France
[4] CHU Bordeaux, Serv Endocrinol, F-33000 Bordeaux, France
[5] CHI Le Raincy Montfermeil, Serv Cardiol, F-93370 Le Raincy Montfermeil, France
[6] CHU Jean Verdier, Serv Endocrinol Diabetol & Nutr, F-93140 Bondy, France
[7] CHU Bichat, Serv Cardiol, F-75018 Paris, France
[8] CHU Toulouse, Serv Cardiol, F-31059 Toulouse, France
[9] CHU Nice, Serv Diabetol Endocrinol, F-06002 Nice, France
[10] CHU Toulouse, Serv Diabetol, F-31059 Toulouse, France
[11] CHU Lariboisiere, Serv Cardiol, F-75010 Paris, France
[12] Serv Readaptat Cardiaque, F-37510 Bois Gibert, France
[13] CHU Lyon, Hop Cardiol Louis Pradel, Serv Endocrinol & Malad Nutr, F-69677 Bron, France
[14] Serv Readaptat Cardiaque, F-21000 Dijon, France
[15] CHU Bichat, Serv Diabetol Endocrinol & Nutr, F-75018 Paris, France
关键词
Diabetes; Acute coronary syndrome; Myocardial infarction; Consensus; Cardiology; Hyperglycaemia; Review; ACUTE MYOCARDIAL-INFARCTION; INTENSIVE INSULIN THERAPY; ABNORMAL GLUCOSE REGULATION; MEDICAL NUTRITION THERAPY; TYPE-2; DIABETIC-PATIENTS; GLUCAGON-LIKE PEPTIDE-1; CARDIOVASCULAR OUTCOMES; CARDIAC REHABILITATION; SECONDARY PREVENTION; NONDIABETIC SUBJECTS;
D O I
10.1016/j.diabet.2011.11.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Diabetes and Cardiovascular Disease study group of the Societe francophone du diabete (SFD, French Society of Diabetes) in collaboration with the Societe francaise de cardiologie (SFC, French Society of Cardiology) have devised a consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up Of acute coronary syndrome (ACS); in particular, it includes the different phases of ACS [the intensive care unit (ICU) period, the post-ICU period and the short-term follow-up period after discharge, including cardiac rehabilitation] and also embraces all of the various diagnostic and therapeutic issues with a view to optimalizing the collaboration between cardiologists and diabetologists. As regards diagnosis, subjects with HbA(1c) greater or equal to 6.5% on admission may be considered diabetic while, in those with no known diabetes and HbA(1c) less than 6.5%, it is recommended that an OGTT be performed 7 to 28 days after ACS. During hospitalization in the ICU, continuous insulin treatment should be initiated in all patients when admission blood glucose levels are greater or equal to 180 mg/dL (10.0 mmol/L) and, in those with previously known diabetes, when preprandial glucose levels are greater or equal to 140 mg/dL (7.77 mmol/L) during follow-up. The recommended blood glucose target is 140-180 mg/dL (7.7-10 mmol/L) for most patients. Following the ICU period, insulin treatment is not mandatory for every patient, and other antidiabetic treatments may be considered, with the choice of optimal treatment depending on the metabolic profile of the patient. Patients should be referred to a diabetologist before discharge from hospital in cases of unknown diabetes diagnosed during ACS hospitalization, of HbA(1c) greater or equal to 8% at the time of admission, or newly introduced insulin therapy or severe/repeated hypoglycaemia. Referral to a diabetologist after hospital discharge is recommended if diabetes is diagnosed by the OGTT, or during cardiac rehabilitation in cases of uncontrolled diabetes (HbA(1c) >= 8%) or severe/repeated hypoglycaemia. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:113 / 127
页数:15
相关论文
共 120 条
[1]   Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S12-S54
[2]   Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study [J].
Andersson, C. ;
Olesen, J. B. ;
Hansen, P. R. ;
Weeke, P. ;
Norgaard, M. L. ;
Jorgensen, C. H. ;
Lange, T. ;
Abildstrom, S. Z. ;
Schramm, T. K. ;
Vaag, A. ;
Kober, L. ;
Torp-Pedersen, C. ;
Gislason, G. H. .
DIABETOLOGIA, 2010, 53 (12) :2546-2553
[3]  
[Anonymous], 992 WHO
[4]  
[Anonymous], 2011, DIABETES CARE S1, V34, pS45
[5]  
[Anonymous], 2009, DIABETES CARE, V32, P119
[6]  
[Anonymous], 2007, EUR J CARDIOVASC S2, V14, pE1
[7]  
[Anonymous], 2008, CIRCULATION, V117, P1610
[8]   Effect of Second-Generation Sulfonylureas on Survival in Patients With Diabetes Mellitus After Myocardial Infarction [J].
Arruda-Olson, Adelaide M. ;
Patch, Richard K., III ;
Leibson, Cynthia L. ;
Vella, Adrian ;
Frye, Robert L. ;
Weston, Susan A. ;
Killian, Jill M. ;
Roger, Veronique L. .
MAYO CLINIC PROCEEDINGS, 2009, 84 (01) :28-33
[9]   Transition From Intravenous to Subcutaneous Insulin Effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome [J].
Avanzini, Fausto ;
Marelli, Giuseppe ;
Donzelli, Walter ;
Busi, Giovanna ;
Carbone, Stefania ;
Bellato, Laura ;
Colombo, Elena Lucia ;
Foschi, Roberto ;
Riva, Emma ;
Roncaglioni, Maria Carla ;
De Martini, Mario .
DIABETES CARE, 2011, 34 (07) :1445-1450
[10]   Metformin: Effects on micro and macrovascular complications in type 2 diabetes [J].
Bailey, Clifford J. .
CARDIOVASCULAR DRUGS AND THERAPY, 2008, 22 (03) :215-224